Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Townson Sharon sold 6,000 Monte Rosa Therapeutics, Inc. shares (Form 4)
Traded Jul 6, 2026 · Filed Jul 7, 2026
On Jul 6, 2026, Townson Sharon (Chief Scientific Officer) sold 6,000 Monte Rosa Therapeutics, Inc. shares at an average US$23.31 for US$140K under a trading plan, leaving 67,845 shares. Filed Jul 7, 2026 (Form 4).
- Sold
- 6,000 shares
- Price
- US$23.31 average (US$23.25 to US$24.13)
- Value
- US$140K
- Holding after
- 67,845 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | Option exercise | 6,000 | US$6.14 | 73,845 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 5,600 | US$23.25 | 68,245 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 400 | US$24.13 | 67,845 | Direct |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Townson Sharon
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Townson Sharon · Jun 25, 2026
- Form 4 · Townson Sharon · Jun 18, 2026
- Form 4 · Townson Sharon · Jun 1, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026